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ABSTRACT 
The elderly reportedly have a significantly higher % of eicosapentaenoic (EPA) and 
docosahexaenoic (DHA) acids in plasma and red cell lipids. However, these results are 
from a few small studies and the health status of the elderly in these studies is for the most 
part unclear. Since the elderly are susceptible to cardiovascular and neurological illnesses 
that seem to be related in part to lower intake of n-3 fatty acids it seems paradoxical that 
their blood levels of EPA and DHA would be higher than in young adults. We report here 
plasma fatty acid profiles and their response to supplementation with two types of fish oils 
from several of our recent studies in the moderately healthy elderly. We define the 
moderately healthy elderly as those who were in good physical condition, had no cognitive 
decline and, if present, in whom hypothyroidism, hyperlipidemia and/or hypertension were 
well-controlled. As shown previously, we confirm the higher % EPA and % total n-3 fatty 
acids (but not DHA) in fasting plasma and extend these findings to include higher plasma 
concentrations (mg/L) of n-3 fatty acids as well. The EPA-predominant supplement raised 
DHA only in the young, whereas the DHA-predominant supplement raised EPA more in 
young than in the elderly. The moderately healthy elderly clearly have higher plasma n-3 
fatty acids but whether this reflects differences in intake versus aging-related changes in 
n-3 fatty acid metabolism remains to be elucidated. 
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INTRODUCTION 
N-3 fatty acids from fish are now generally recognized as beneficial for optimal 
function of the cardiovascular system in adults, whether consumed as fish or as fish oil 
supplements. Long term fish intake is also associated with a lower risk of cognitive decline 
and Alzheimer’s disease during aging [1, 2], but it is not yet clear that n-3 fatty acid or fish 
oil supplements can replace long term fish intake for this purpose [3].  
Because of the increasing risk of deteriorating health of the cardiovascular system 
and brain with age, we and others have sought to establish whether healthy aging is 
associated with changes in plasma n-3 fatty acid content or response to n-3 fatty acid 
supplementation that would leave the elderly with poorer n-3 fatty acid status that 
predisposes them to these degenerative diseases. In fact, perhaps surprisingly, in both 
plasma and red blood cells, several papers show that the content of eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA) rises significantly from the second to the seventh 
decade of life [4-9]. Nevertheless, these studies all had significant limitations, including 
small numbers of subjects. Furthermore, although 65 years old is frequently used as 
reference, there is no official or widely accepted definition of elderly, so the cut-off is often 
as low as 50 y old. Furthermore, information about the health status, blood chemistry, 
cognitive function or physical activity of elderly research subjects is rarely given in 
sufficient detail to establish whether or not the data reported are for the healthy elderly.  
Our aim here is to report more detailed information on anthropometry, blood 
chemistry, as well as fasting plasma fatty acid profiles and responses to two types of n-3 
fatty acid supplementation of young adults and elderly living in or around the city of 
Sherbrooke in southern Québec whom we classify as «moderately healthy». We base this 
definition on their active lifestyle, normal cognition and relatively good physical condition. 
Nevertheless, because most of our subjects used prescription medications to control their 
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blood pressure and blood lipids in particular, without which they would not have been 
within accepted limits for these parameters, we define them here as «moderately healthy». 
The data reported here are pooled from our published [8-10] and unpublished studies. 
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METHODS 
Young adults were defined as between 18-30 y, while the elderly group was ≥65 y 
old. There were 24-28 participants in each age group (except as noted in the Tables). 
They were recruited by public announcements and word of mouth. All were pre-screened 
for medical history, and excluded if they had diabetes, evidence of overt hepatic or renal 
disease, or untreated hypertension, dyslipidemia or thyroid disease. Fasting glucose and 
hemoglobin A1c were used to rule out the presence of diabetes or probable glucose 
intolerance. All subjects had a score of at least 28/30 on the Mini-Mental State Exam. 
None were smokers and none in the young age group were on prescribed medications.  
Unmedicated subjects were preferred but those on medications for elevated blood 
pressure, hyperlipidemia or inflammatory joint pain were accepted into the study if their 
blood pressure and blood lipids were within normal limits for at least 6 months. In the 
elderly group, 29% were medication free, 18% were taking one prescribed medication, 
32% were taking two different medications and 21% took 3-7 different medications. By 
type of medication, 25% of the elderly were on hypolipidemics, 43% on antihypertensives, 
25% on a non-steroidal anti-inflammatory drug, 21% on thyroid hormone replacement, and 
25% on inhibitors of bone resorption. Other medications were also consumed but less 
commonly, including beta-blockers, antidepressants, sedatives, conjugated estrogen, 
proton pump inhibitors and autacoids, each of which was used by no more than one 
subject each.  
Approval for all studies was obtained from the Research Ethics Committee of the 
Health and Social Services Center – Sherbrooke University Geriatrics Institute, which 
oversees all human research done at the Research Center on Aging. All subjects gave 
informed, written consent before participating. 
Plasma from venous forearm blood samples obtained after a 10-12 h overnight fast 
was kept at -20°C until analyzed. Triglycerides, cholesterol, glucose, free fatty acids, and 
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-hydroxybutyrate were analyzed in our lab by clinical chemistry analyzer (Dimension 
Xpand Plus (Siemans Healthcare Diagnostics, Deerfield, IL, USA). Others plasma 
metabolites and the complete blood cell count were done by the clinical laboratory of our 
affiliated hospital (CHUS, Sherbrooke, QC). Plasma insulin was analyzed by enzyme-
linked immunosorbent assay (Alpco, Salem, NH) with a Victor X4 multilabel plate reader 
(Perkin Elmer, Woodbridge, ON).   
Fatty acid profiles of plasma total lipids were analyzed by capillary gas 
chromatography as previously described [9]. Some subjects were then given an n-3 
supplement enriched in DHA (680 mg DHA/d plus 323 mg EPA/d ) for 3 wk, or a 
supplement enriched in EPA (1480 mg EPA/d plus 250 mg DHA/d) for 6 wk, and fatty acid 
profiles periodically analyzed in plasma samples (see Figures 1, 2).  
Mann-Whitney non-parametric tests were used to compare data between the young 
and elderly groups. The paired sample Wilcoxen signed Rank test was used to assess the 
effect of the n-3 fatty acid supplements. A p value < 0.05 was considered statistically 
significant. 
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RESULTS 
 The mean age of the elderly was 74 y old and they were 51 years older than the 
young subjects. The elderly were 0.07 m shorter (5%; p<0.01) and 0.8 kg heavier (1.1%, 
n.s.), resulting in a body mass index 12% higher (p<0.05) than the young subjects (Table 
1). Fasting plasma triglycerides, total cholesterol, LDL cholesterol, glucose, thyroid 
stimulating hormone, and hemoglobin A1c were 10-40% higher in the elderly group 
(p<0.01), but HDL cholesterol, free fatty acids, -hydroxybutyrate, insulin, and C-reactive 
protein were not different. Red cell count, albumin, alanine aminotransferase and 
lymphocyte count were 5-23% lower in the elderly (Table 1). 
Expressed as a percentage of total extracted fatty acids, fatty acid profiles of fasting 
plasma total lipids from the elderly group had 11% higher total monounsaturates and 32% 
higher total n-3 polyunsaturates, no difference in individual or total saturates, and 7% 
lower total n-6 polyunsaturates (all p<0.05; Table 2). Amongst the n-6 polyunsaturates, 
only 18:2n-6 (linoleic acid) was significantly lower in the elderly (-12%; p<0.01), while 
amongst the n-3 fatty acids, only EPA and 22:5n-3 (n-3 docosapentaenoic acid) were 
higher in the elderly (+100% and +25%, respectively, p<0.05-0.01). Expressed as 
concentrations (mg/L), total plasma fatty acids were 29% higher in the elderly (p<0.01), 
with the difference being much more for the n-3 polyunsaturates (+74%) than for the 
saturates, monounsaturates or n-6 polyunsaturated fatty acids (+22 to +41%; Table 3). 
Individually, concentrations of all the n-3 polyunsaturates were significantly higher in the 
elderly by +40% (18:3n-3), +63% (DHA), +85% (22:5n-3) and +142% (EPA).  
After the supplementation period, both the EPA- and DHA-predominant 
supplements raised plasma EPA in the young and elderly. The EPA-predominant 
supplement raised plasma DHA only in the young subjects and to a level equivalent to that 
in the elderly. The DHA-predominant supplement raised plasma DHA equally in the young 
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and elderly (+70%) but raised plasma EPA more in young than in the elderly (126% vs. 
59%, respectively; Figures 1,2).  
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DISCUSSION 
We report here plasma long chain fatty acid profiles and response to two types of n-
3 fatty acid supplementation in moderately healthy elderly and young adults in southern 
Québec. As reported elsewhere [7, 11] and compared to our young adults, the moderately 
healthy elderly in this study had a higher proportion of total n-3 fatty acids in plasma total 
lipids. This higher proportion of n-3 fatty acids in plasma was statistically significant only 
for EPA and 22:5n-3 (Table 2). Expressed as concentrations, all the n-3 fatty acids were 
40-142% higher in plasma total lipids; this difference was in part due to the 29% higher 
total plasma fatty acids in the elderly, but % composition of the n-3 fatty acids was still 
higher than for other fatty acids (Table 3). We are not aware of any previous reports of 
higher n-3 concentration in plasma total lipids in the healthy elderly. Our present data 
confirm previously published reports suggesting that the n-3 fatty acid status of red blood 
cells [4-6] and plasma [7-9, 11] is higher in moderately healthy elderly compared to 
younger adults. Although most of our elderly subjects were on one or more prescription 
medications, otherwise, they were in relatively good physical and cognitive health. Hence, 
on the face of it and whether expressed as % composition or concentration, the 
moderately healthy elderly have higher fasting plasma n-3 fatty acid status than young 
adults. 
Higher plasma (and red cell) plasma n-3 fatty acid status in the elderly would seem 
to be due to higher fish and/or seafood intake. This is principally because higher plasma 
EPA and DHA is usually a direct reflection of higher EPA and DHA intake, the principal 
sources of which are fish and seafood. Furthermore, the parent n-3 fatty acid, 18:3n-3 (-
linolenic acid), cannot be synthesized de novo in humans and since there is little 
conversion of 18:3n-3 to EPA and DHA in humans [12], plasma EPA and DHA originate 
mostly from their intake.  
Prostagl, Leukotri Essential Fatty Acids (FACS 2009 Proceedings)  
Submitted 2 October 2009 10 
Nevertheless, there are several reasons why these data need to be interpreted 
cautiously: First, we did not record their dietary habits so we cannot confirm whether our 
elderly subjects actually consumed more fish. Second, the elderly are more susceptible to 
cognitive decline [1, 3, 13], but risk of cognitive decline is lower in those consuming more 
fish or n-3 fatty acids, so this increased susceptibility seems paradoxical if indeed the 
plasma n-3 fatty acid status is higher in the elderly. Third, a single blood measurement of 
EPA and DHA correlates well with fish intake or fish oil supplementation [14] but tells little 
about the n-3 fatty acid status to the brain or other organs at risk of n-3 fatty acid 
insufficiency during aging. Fourth, apolipoprotein E4 significantly raises fasting plasma 
EPA and DHA [15,16] and reduces the plasma EPA and DHA response to a fish oil 
supplement [16], but whether these effects influences apparent n-3 fatty acid status of the 
elderly is not yet known. Fifth, our studies with two types of n-3 fatty acid supplements [8, 
9; Figures 1,2] indicate that subtle differences exist in the way the healthy elderly process 
n-3 fatty acids through the blood. Thus, we believe it is premature to conclude that higher 
fasting blood EPA and DHA in the elderly is necessarily a result of higher fish intake.  
A significant proportion of the elderly participants in this study was on medications 
and had plasma metabolite profiles significantly different from the young group (Table 1). 
Despite the use of medications for blood pressure and blood lipid control in particular, our 
moderately healthy elderly still had higher plasma cholesterol and triglycerides. They also 
had higher plasma thyroid stimulating hormone and glucose, as well as signs of mild 
glucose intolerance. Nevertheless, their fasting plasma free fatty acids, ketones, insulin 
and C-reactive protein were not different from those of the young subjects. Hence, we 
defined them as «moderately healthy» on the basis of stable and effective pharmaceutical 
control of blood pressure and blood lipids, normal or near normal plasma metabolites and 
blood chemistry, hormones, and enzymes, absence of cognitive decline, and relatively 
good physical condition.   
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Higher blood n-3 fatty acid status than is commonly observed in North America is 
desirable at all ages and is most readily achieved by higher fish intake. Nevertheless, in 
the elderly, higher fasting plasma or red cell n-3 fatty acids may in part be due to higher 
fish intake but may also be due to aging-related changes in n-3 fatty acid metabolism. This 
uncertainty requires further investigation so as to correctly assess n-3 fatty acid status of 
the elderly. We are presently investigating these aging-related changes in more detail 
using 13C-labeled DHA. 
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TABLE 1 
Anthropometric and fasting plasma measurements in moderately healthy elderly compared 
to young adults. Where significant differences were present between the young and 
elderly, the % difference is also shown (% )#. 
 Young Elderly %  
Age (y) 23.7  3.2 74.4  3.9 *  
Height (m) 1.73  0.10 1.65  0.09  * -5  
Weight (kg) 71.2  18.0 72.0  12.7  
Body mass index (kg/m2) 23.8  5.4 26.6  4.1  * +12  
Triglycerides (mmol/L) 1.0  0.4 1.4  0.5  * +40  
Total Cholesterol (mmol/L) 4.1  0.7 5.7  1.2  * +37  
Glucose (mmol/L) 5.1  0.6 5.8  0.7  * +14  
Free fatty acids (mol/L) 508  207 605  218  
-Hydroxybutyrate (μmol/L) 69  75 75  52  
Insulin (mIU/L) 5.8  4.4 5.3  3.3  
Hemoglobin A1c (%) 5.0  0.3 5.5  0.4  * +10  
HDL cholesterol (mmol/L) 1.3  0.4 1.4  0.3  
LDL cholesterol (mmol/L) 2.4  0.6 3.1  1.0  * +29  
Thyroid stimulating hormone (mIU/L) 2.0  0.8 2.7  1.2  * +35  
Serum aspartate aminotransferase (U/L) 30  10 28  7  
Serum alanine aminotransferase (U/L) 40  17 31  9  * -23  
Albumen (g/L) 45  4 42  3  * -8  
Creatinine (μmol/L) 86  16 86  11  
C-reactive protein (mg/L) 3.8  2.3 4.8  3.2  
# mean±SD for n = 24-28, except insulin (n=11 in the young; n=13 in the elderly). 
* p<0.05 
## NOTE: Hemoglobin (g/L), hematocrit (%), platelet, monocyte and leucocyte counts did 
not differ between groups, but red cell (4.7±0.3 vs. 4.9±0.4 X1012/L; p<0.05) and 
lymphocyte (0.6±0.5 vs. 0.5±0.5 X103/L; p<0.05) counts were lower in the elderly. 
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TABLE 2 
Fasting fatty acid profiles (%, mean±SD) in plasma total lipids of moderately healthy young 
and moderately elderly subjects. Where significant differences were present between the 
young and elderly, the % difference is also shown (% ). 
 Young (n=26) Elderly (n=25) %  
14:0 1.0  0.4 1.0  0.3  
16:0 23.9  2.9 23.3  2.7  
18:0 7.9  2.4 7.4  1.7  
Sum Saturates 32.7  4.8 31.8  3.9  
16:1n-7 2.0  0.9 2.7  1.6  * +32  
18:1n-9 21.3  2.2 23.3  2.6  * +9 
18:1n-7 1.7  0.3 1.9  0.3  * +15  
Sum Monounsaturates 25.0  2.7 27.8  3.3  * +11  
18:2n-6 31.7  4.3 28.0  6.7  * -12  
20:3n-6 1.5  0.3 1.5  0.3  
20:4n-6 6.0  1.0 6.8  1.8  
Sum n-6 Polyunsaturates 39.3  4.4 36.4  6.1  * -7  
18:3n-3 0.8  0.5 0.8  0.3  
20:5n-3 0.5  0.3 1.0  0.5  * +84  
22:5n-3 0.4  0.2 0.5  0.2  * +40  
22:6n-3 1.4  0.5 1.7  0.8  
Sum n-3 Polyunsaturates 3.1  1.0 4.0  1.4  * +32  
* p<0.05 
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TABLE 3 
Fasting fatty acid profiles (mg/L, mean±SD) in plasma total lipids of healthy young and 
moderately elderly subjects. Where significant differences were present between the 
young and elderly, the % difference is also shown (% ). 
 Young (n=26) Elderly (n=25) %  
14:0 27  16 38  16 * +42  
16:0 665  286 826  209 * +24  
18:0 216  103 265  98 * +23  
Sum Saturates 907  385 1,128  302 * +24  
16:1n-7 59  40 98  69 * +65  
18:1n-9 594  254 823  210 * +39  
18:1n-7 47  22 67  18 * +43  
Sum Monounsaturates 700  306 988  266 * +41  
18:2n-6 858  314 1,016  374 * +18  
20:3n-6 42  20 52  14 * +24  
20:4n-6 167  74 235  61 * +41  
Sum n-6 Polyunsaturates 1,067  394 1,304  402 * +22  
18:3n-3 22  15 30  15 * +40  
20:5n-3 15  9 36  24 * +142  
22:5n-3 10  5 18  8 * +85  
22:6n-3 37  20 60  35 * +63  
Sum n-3 Polyunsaturates 83  37 145  77 * +74  
TOTAL  2,758  1057 3,564  919 * +29  
* p<0.05 
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EPA and DHA in plasma total lipids in healthy young (n= 14) and elderly humans (n = 13), 
before (white) and after (gray) a DHA-predominant omega 3 supplementation (680 mg 
DHA/d, 323 mg EPA/d) given for 3 wk. * significant difference between young and elderly, 
# significant difference after supplementation. 
 
Figure 2 
EPA and DHA in plasma total lipids in healthy young (n=10) and elderly humans (n =10) 
before (white) and after (gray) an EPA-predominant omega 3 supplementation (1480 mg 
EPA/d; 250 mg DHA/d) for 6 wk. Modified from [9].* significant difference between young 
and elderly, # significant difference after supplementation. 
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Figure 2  
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